-
1
-
-
26444506310
-
Seminal reservoirs during an HIV type 1 eradication trial
-
NUNNARI G, LETO D, SULLIVAN J, XU Y, MEHLMAN KE, KULKOSKY J, POMERANTZ RJ. Seminal reservoirs during an HIV type 1 eradication trial. AIDS Res Hum Retroviruses 2005; 21: 768-775.
-
(2005)
AIDS Res Hum Retroviruses
, vol.21
, pp. 768-775
-
-
Nunnari, G.1
Leto, D.2
Sullivan, J.3
Xu, Y.4
Mehlman, K.E.5
Kulkosky, J.6
Pomerantz, R.J.7
-
2
-
-
24344495217
-
HIV type 1 cervicovaginal reservoirs in the era of HAART
-
NUNNARI G, SULLIVAN J, XU Y, NYIRJESY P, KULKOSKY J, CAVERT W, FRANK I, POMERANTZ RJ. HIV type 1 cervicovaginal reservoirs in the era of HAART. AIDS Res Hum Retroviruses 2005; 21: 714-718.
-
(2005)
AIDS Res Hum Retroviruses
, vol.21
, pp. 714-718
-
-
Nunnari, G.1
Sullivan, J.2
Xu, Y.3
Nyirjesy, P.4
Kulkosky, J.5
Cavert, W.6
Frank, I.7
Pomerantz, R.J.8
-
3
-
-
27144546784
-
Exogenous IL-7 induces Fas-Mediated human neuronal apoptosis: Potential effects during human immunodeficiency virus type 1 infection
-
NUNNARI G, XU Y, ACHEAMPONG EA, FANG J, DANIEL R, ZHANG C, ZHANG H, MUKHTAR M, POMERANTZ RJ. Exogenous IL-7 induces Fas-Mediated human neuronal apoptosis: Potential effects during human immunodeficiency virus type 1 infection. J Neurovirol 2005; 11: 319-328.
-
(2005)
J Neurovirol
, vol.11
, pp. 319-328
-
-
Nunnari, G.1
Xu, Y.2
Acheampong, E.A.3
Fang, J.4
Daniel, R.5
Zhang, C.6
Zhang, H.7
Mukhtar, M.8
Pomerantz, R.J.9
-
4
-
-
27644454187
-
IL-7 As a potential therapy for HIV-1-Infected individuals
-
NUNNARI G, POMERANTZ RJ. IL-7 as a potential therapy for HIV-1-Infected individuals. Expert Opin Biol Ther 2005; 5: 1421-1426.
-
(2005)
Expert Opin Biol Ther
, vol.5
, pp. 1421-1426
-
-
Nunnari, G.1
Pomerantz, R.J.2
-
5
-
-
3042698107
-
Malignancy-Related causes of death in human immunodeficiency virus infected patients in the era of highly active antiretroviral therapy
-
BONNET F, LEWDEN C, MAY T, HERIPRET L, JOUGLA E, BEVILACQUA S, COSTAGLIOLA D, SALMON D, CHENE G, MORLAT P. Malignancy-Related causes of death in human immunodeficiency virus infected patients in the era of highly active antiretroviral therapy. Cancer 2004; 101: 317-324.
-
(2004)
Cancer
, vol.101
, pp. 317-324
-
-
Bonnet, F.1
Lewden, C.2
May, T.3
Heripret, L.4
Jougla, E.5
Bevilacqua, S.6
Costagliola, D.7
Salmon, D.8
Chene, G.9
Morlat, P.10
-
6
-
-
84868302810
-
-
Pancreas Jun 24. [Epub ahead of print]
-
ZANET E, BERRETTA M, DI BENEDETTO F, TALAMINI R, BALLARIN R, NUNNARI G, BERRETTA S, RIDOLFO A, LLESHI A, ZANGHÌ A, CAPPELLANI A, TIRELLI U. Pancreatic Cancer in HIV-Positive Patients: A Clinical Case-Control Study. Pancreas 2012 Jun 24. [Epub ahead of print]
-
(2012)
Pancreatic Cancer in HIV-Positive Patients: A Clinical Case-Control Study
-
-
Zanet, E.1
Berretta, M.2
Di Benedetto, F.3
Talamini, R.4
Ballarin, R.5
Nunnari, G.6
Berretta, S.7
Ridolfo, A.8
Lleshi, A.9
Zanghì, A.10
Cappellani, A.11
Tirelli, U.12
-
7
-
-
41949141188
-
Kaposi's sarcoma after liver transplantation
-
DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, BALLARIN R, COCCHI S, POTENZA L, LUPPI M, GERUNDA GE. Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 2008; 134: 653-658.
-
(2008)
J Cancer Res Clin Oncol
, vol.134
, pp. 653-658
-
-
Di Benedetto, F.1
Di Sandro, S.2
De Ruvo, N.3
Berretta, M.4
Masetti, M.5
Montalti, R.6
Ballarin, R.7
Cocchi, S.8
Potenza, L.9
Luppi, M.10
Gerunda, G.E.11
-
8
-
-
73949094320
-
AIDS-Related Kaposi's sarcoma: State of the art and therapeutic strategies
-
MARTELLOTTA F, BERRETTA M, VACCHER E, SCHIOPPA O, ZANET E, TIRELLI U. AIDS-Related Kaposi's sarcoma: State of the art and therapeutic strategies. Curr HIV Res 2009; 7: 634-638.
-
(2009)
Curr HIV Res
, vol.7
, pp. 634-638
-
-
Martellotta, F.1
Berretta, M.2
Vaccher, E.3
Schioppa, O.4
Zanet, E.5
Tirelli, U.6
-
9
-
-
77958571821
-
Excess mortality for non-AIDSdefining cancers among people with AIDS
-
ZUCCHETTO A, SULIGOI B, DE PAOLI A, PENNAZZA S, POLESE J, BRUZZONE S, REZZA G, DE PAOLI P, DAL MASO L, SERRAINO D. Excess mortality for non-AIDSdefining cancers among people with AIDS. Clin Infect Dis 2010; 51: 1099-1101.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 1099-1101
-
-
Zucchetto, A.1
Suligoi, B.2
De Paoli, A.3
Pennazza, S.4
Polese, J.5
Bruzzone, S.6
Rezza, G.7
De Paoli, P.8
Dal Maso, L.9
Serraino, D.10
-
10
-
-
73349120643
-
A metaanalysis of the incidence of non-AIDS cancers in HIV-Infected individuals
-
SHIELS MS, COLE SR, KIRK GD, POOLE C. A metaanalysis of the incidence of non-AIDS cancers in HIV-Infected individuals. J Acquir Immune Defic Syndr 2009; 52: 611-622.
-
(2009)
J Acquir Immune Defic Syndr
, vol.52
, pp. 611-622
-
-
Shiels, M.S.1
Cole, S.R.2
Kirk, G.D.3
Poole, C.4
-
11
-
-
0242539770
-
Therapeutic approaches to AIDSrelated malignancies
-
BERRETTA M, CINELLI R, MARTELLOTTA F, SPINA M, VACCHER E, TIRELLI U. Therapeutic approaches to AIDSrelated malignancies. Oncogene 2003; 22: 6646-6659.
-
(2003)
Oncogene
, vol.22
, pp. 6646-6659
-
-
Berretta, M.1
Cinelli, R.2
Martellotta, F.3
Spina, M.4
Vaccher, E.5
Tirelli, U.6
-
12
-
-
77955056771
-
Cancer incidence in people with AIDS in Italy
-
Cancer Aids Registries Linkage Study Cancer Aids Registries Linkage Study
-
POLESEL J, FRANCESCHI S, SULIGOI B, CROCETTI E, FALCINI F, GUZZINATI S, VERCELLI M, ZANETTI R, TAGLIABUE G, RUSSO A, LUMINARI S, STRACCI F, DE LISI V, FERRETTI S, MANGONE L, BUDRONI M, LIMINA RM, PIFFER S, SERRAINO D, BELLÙ F, GIACOMIN A, DONATO A, MADEDDU A, VITARELLI S, FUSCO M, TESSANDORI R, TUMINO R, PISELLI P, DAL MASO L; CANCER AND AIDS REGISTRIES LINKAGE STUDY CANCER; AIDS REGISTRIES LINKAGE STUDY, LISE M, ZUCCHETTO A, DE PAOLI A, INTRIERI T, VATTIATO R, ZAMBON P, PUPPO A, PATRIARCA S, TITTARELLI A, AUTELITANO M, CIRILLI C, LA ROSA F, SGARGI P, DI FELICE E, CESARACCIO R, DONATO F, FRANCHINI S, ZANIER L, VITTADELLO F, VERCELLINO PC, SENATORE G, CONTRINO ML, ANTONINI S, PALOMBINO R, MASPERO S, LA ROSA MG, CAMONI L, REGINE V. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010; 127: 1437-1445.
-
(2010)
Int J Cancer
, vol.127
, pp. 1437-1445
-
-
Polesel, J.1
Franceschi, S.2
Suligoi, B.3
Crocetti, E.4
Falcini, F.5
Guzzinati, S.6
Vercelli, M.7
Zanetti, R.8
Tagliabue, G.9
Russo, A.10
Luminari, S.11
Stracci, F.12
De Lisi, V.13
Ferretti, S.14
Mangone, L.15
Budroni, M.16
Limina, R.M.17
Piffer, S.18
Serraino, D.19
Bellù, F.20
Giacomin, A.21
Donato, A.22
Madeddu, A.23
Vitarelli, S.24
Fusco, M.25
Tessandori, R.26
Tumino, R.27
Piselli, P.28
Dal Maso, L.29
Lise, M.30
Zucchetto, A.31
De Paoli, A.32
Intrieri, T.33
Vattiato, R.34
Zambon, P.35
Puppo, A.36
Patriarca, S.37
Tittarelli, A.38
Autelitano, M.39
Cirilli, C.40
La Rosa, F.41
Sgargi, P.42
Di Felice, E.43
Cesaraccio, R.44
Donato, F.45
Franchini, S.46
Zanier, L.47
Vittadello, F.48
Vercellino, P.C.49
Senatore, G.50
Contrino, M.L.51
Antonini, S.52
Palombino, R.53
Maspero, S.54
La Rosa, M.G.55
Camoni, L.56
Regine, V.57
more..
-
13
-
-
33947713110
-
Cancer incidence in AIDS patients in Catalonia, Spain
-
GALCERAN J, MARCOS-GRAGERA R, SOLER M, ROMAGUERA A, AMEIJIDE A, IZQUIERDO A, BORRÀS J, DE SANJOSÉ S, CASABONA J. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 2007; 43: 1085-1091.
-
(2007)
Eur J Cancer
, vol.43
, pp. 1085-1091
-
-
Galceran, J.1
Marcos-Gragera, R.2
Soler, M.3
Romaguera, A.4
Ameijide, A.5
Izquierdo, A.6
Borràs, J.7
De Sanjosé, S.8
Casabona, J.9
-
14
-
-
0344412949
-
GICAT; ICONA Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-Related Kaposi sarcoma
-
NASTI G, MARTELLOTTA F, BERRETTA M, MENA M, FASAN M, DI PERRI G, TALAMINI R, PAGANO G, MONTRONI M, CINELLI R, VACCHER E, D'ARMINIO MONFORTE A, TIRELLI U; GICAT; ICONA. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-Related Kaposi sarcoma. Cancer 2003; 98: 2440-2446.
-
(2003)
Cancer
, vol.98
, pp. 2440-2446
-
-
Nasti, G.1
Martellotta, F.2
Berretta, M.3
Mena, M.4
Fasan, M.5
Di Perri, G.6
Talamini, R.7
Pagano, G.8
Montroni, M.9
Cinelli, R.10
Vaccher, E.11
D'arminio Monforte, A.12
Tirelli, U.13
-
15
-
-
33746912330
-
The growing problem of non-AIDS-Defining malignancies in HIV
-
PANTANOWITZ L, SCHLECHT HP, DEZUBE BJ. The growing problem of non-AIDS-Defining malignancies in HIV. Curr Opin Oncol 2006; 18: 469-478.
-
(2006)
Curr Opin Oncol
, vol.18
, pp. 469-478
-
-
Pantanowitz, L.1
Schlecht, H.P.2
Dezube, B.J.3
-
16
-
-
77954050860
-
Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection
-
BERRETTA M, LLESHI A, CAPPELLANI A, BEARZ A, SPINA M, TALAMINI R, CACOPARDO B, NUNNARI G, MONTESARCHIO V, IZZI I, LANZAFAME M, NASTI G, BASILE F, BERRETTA S, FISICHELLA R, SCHIANTARELLI C C, GARLASSI E, RIDOLFO A, GUELLA L, TIRELLI U. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res 2010; 8: 218-222.
-
(2010)
Curr HIV Res
, vol.8
, pp. 218-222
-
-
Berretta, M.1
Lleshi, A.2
Cappellani, A.3
Bearz, A.4
Spina, M.5
Talamini, R.6
Cacopardo, B.7
Nunnari, G.8
Montesarchio, V.9
Izzi, I.10
Lanzafame, M.11
Nasti, G.12
Basile, F.13
Berretta, S.14
Fisichella, R.15
Schiantarelli C, C.16
Garlassi, E.17
Ridolfo, A.18
Guella, L.19
Tirelli, U.20
more..
-
17
-
-
0034047066
-
Pathogenesis of HIV-1 infection within bone marrow cells
-
KULKOSKY J, BOUHAMDAN M, GEIST A, NUNNARI G, PHINNEY DG, POMERANTZ RJ. Pathogenesis of HIV-1 infection within bone marrow cells. Leuk Lymphoma 2000; 37: 497-515.
-
(2000)
Leuk Lymphoma
, vol.37
, pp. 497-515
-
-
Kulkosky, J.1
Bouhamdan, M.2
Geist, A.3
Nunnari, G.4
Phinney, D.G.5
Pomerantz, R.J.6
-
18
-
-
60549102162
-
Changes in cancer mortality among HIV-Infected patients: The mortalité 2005 survey
-
MORLAT P AND AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HÉPATITES VIRALES EN19 MORTALITÉ STUDY GROUP AND THE MORTAVIC STUDY GROUP
-
BONNET F, BURTY C, LEWDEN C, COSTAGLIOLA D, MAY T, BOUTELOUP V, ROSENTHAL E, JOUGLA E, CACOUB P, SALMON D, CHÉNE G, MORLAT P, AND AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HÉPATITES VIRALES EN19 MORTALITÉ STUDY GROUP AND THE MORTAVIC STUDY GROUP. Changes in cancer mortality among HIV-Infected patients: The mortalité 2005 survey. Clin Infect Dis 2009; 48: 633-639.
-
Clin Infect Dis
, vol.2009
, Issue.48
, pp. 633-639
-
-
Bonnet, F.1
Burty, C.2
Lewden, C.3
Costagliola, D.4
May, T.5
Bouteloup, V.6
Rosenthal, E.7
Jougla, E.8
Cacoub, P.9
Salmon, D.10
Chéne, G.11
-
19
-
-
77951819361
-
The antiretroviral therapy cohort collaboration. Causes of death in HIV-1-Infected patients treated with antiretroviral therapy, 1996-2006: Collaborative analysis of 13 HIV cohort studies
-
GILL J, MAY M, LEWDEN C, SAAG M, MUGAVERO M, REISS P, LEDERGERBER B, MOCROFT A, HARRIS R, FUX CA, JUSTICE A, COSTAGLIOLA D, CASABONA J, HOGG RS, KHAYKIN P, LAMPE F, VEHRESCHILD J, STERNE JA, GILL J, LEWDEN C, SAAG M, EGGER M, MUGAVERO M, REISS P, LEDERGERBER B, MOCROFT A, HARRIS R, MAY M, STERNE JA, BRODT HR, CASABONA J, CHENE G, COSTAGLIOLA D, DABIS F, MONFORTE AD, DE WOLF F, EGGER M, FATKENHEUER G, GILL J, GUEST J, HOGG RS, JUSTICE A, KIRK O, KITAHATA M, LAMPE F, LEDERGERBER B, REISS P, SAAG M, STERLING T, MAY M, HARRIS R, STERNE J. The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-Infected patients treated with antiretroviral therapy, 1996-2006: Collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50: 1387-1396.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 1387-1396
-
-
Gill, J.1
May, M.2
Lewden, C.3
Saag, M.4
Mugavero, M.5
Reiss, P.6
Ledergerber, B.7
Mocroft, A.8
Harris, R.9
Fux, C.A.10
Justice, A.11
Costagliola, D.12
Casabona, J.13
Hogg, R.S.14
Khaykin, P.15
Lampe, F.16
Vehreschild, J.17
Sterne, J.A.18
Gill, J.19
Lewden, C.20
Saag, M.21
Egger, M.22
Mugavero, M.23
Reiss, P.24
Ledergerber, B.25
Mocroft, A.26
Harris, R.27
May, M.28
Sterne, J.A.29
Brodt, H.R.30
Casabona, J.31
Chene, G.32
Costagliola, D.33
Dabis, F.34
Monforte, A.D.35
De Wolf, F.36
Egger, M.37
Fatkenheuer, G.38
Gill, J.39
Guest, J.40
Hogg, R.S.41
Justice, A.42
Kirk, O.43
Kitahata, M.44
Lampe, F.45
Ledergerber, B.46
Reiss, P.47
Saag, M.48
Sterling, T.49
May, M.50
Harris, R.51
Sterne, J.52
more..
-
20
-
-
84861459509
-
Comment on Lung cancer in the Swiss HIV Cohort Study: Role of smoking, immunodeficiency and pulmonary infection
-
BEARZ A, VACCHER E, TALAMINI R, BERRETTA M, TIRELLI U. Comment on "Lung cancer in the Swiss HIV Cohort Study: Role of smoking, immunodeficiency and pulmonary infection". Br J Cancer 2012; 106: 1899-1900.
-
(2012)
Br J Cancer
, vol.106
, pp. 1899-1900
-
-
Bearz, A.1
Vaccher, E.2
Talamini, R.3
Berretta, M.4
Tirelli, U.5
-
21
-
-
84866365069
-
The Role Of Micronutrients In The Diet Of HIV-1-Infected individuals
-
NUNNARI G, COCO C, PINZONE MR, PAVONE P, BERRETTA M, DI ROSA M, SCHNELL M, CALABRESE G, CACOPARDO B. The role of micronutrients in the diet of HIV-1-Infected individuals. Front Biosci (Elite Ed) 2012; 4: 2442-2456.
-
(2012)
Front Biosci (Elite Ed
, vol.4
, pp. 2442-2456
-
-
Nunnari, G.1
Coco, C.2
Pinzone, M.R.3
Pavone, P.4
Berretta, M.5
Di Rosa, M.6
Schnell, M.7
Calabrese, G.8
Cacopardo, B.9
-
22
-
-
34347323902
-
Incidence of cancers in people with HIV/ AIDS compared with immunosuppressed transplant recipients: A meta-Analysis
-
GRULICH AE, VAN LEEUWEN MT, FALSTER MO, VAJDIC CM. Incidence of cancers in people with HIV/ AIDS compared with immunosuppressed transplant recipients: A meta-Analysis. Lancet 2007; 370: 59-67.
-
(2007)
Lancet
, vol.370
, pp. 59-67
-
-
Grulich, A.E.1
Van Leeuwen, M.T.2
Falster, M.O.3
Vajdic, C.M.4
-
23
-
-
25144457680
-
Non-AIDS-Defining cancers and HIV infection
-
LIM ST, LEVINE AM. Non-AIDS-Defining cancers and HIV infection. Curr HIV/AIDS Rep 2005; 2(3): 146-153.
-
(2005)
Curr HIV/AIDS Rep
, vol.2
, Issue.3
, pp. 146-153
-
-
Lim, S.T.1
Levine, A.M.2
-
24
-
-
25144522188
-
Incidence and risk factors for the occurrence of non-AIDS defining cancer among human immunodeficiency virus infected individuals
-
BURGI A, BRODINE S, WEGNER S, MILAZZO M, WALLACE MR, SPOONER K, BLAZES DL, AGAN BK, ARMSTRONG A, FRASER S, CRUM NF. Incidence and risk factors for the occurrence of non-AIDS defining cancer among human immunodeficiency virus infected individuals. Cancer 2005; 104: 1505-1511.
-
(2005)
Cancer
, vol.104
, pp. 1505-1511
-
-
Burgi, A.1
Brodine, S.2
Wegner, S.3
Milazzo, M.4
Wallace, M.R.5
Spooner, K.6
Blazes, D.L.7
Agan, B.K.8
Armstrong, A.9
Fraser, S.10
Crum, N.F.11
-
25
-
-
20144381973
-
Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
-
CLIFFORD GM, POLESEL J, RICKENBACH M, DAL MASO L, KEISER O, RAPITI E, LEVI F, JUNDT G, FISH T, BORDONI A, DE WECK D, FRANCESCHI S. Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-432.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 425-432
-
-
Clifford, G.M.1
Polesel, J.2
Rickenbach, M.3
Dal Maso, L.4
Keiser, O.5
Rapiti, E.6
Levi, F.7
Jundt, G.8
Fish, T.9
Bordoni, A.10
De Weck, D.11
Franceschi, S.12
-
26
-
-
58149120842
-
Trends in the incidence of cancers among HIV-Infected persons and the impact of antiretroviral therapy: A 20-Year cohort study
-
CRUM-CIANFLONE N, HULLSIEK KH, MARCONI V, WEINTROB A, GANESAN A, BARTHEL RV, FRASER S, AGAN BK, WEGNER S. Trends in the incidence of cancers among HIV-Infected persons and the impact of antiretroviral therapy: A 20-Year cohort study. AIDS 2009; 23: 41-50.
-
(2009)
AIDS
, vol.23
, pp. 41-50
-
-
Crum-Cianflone, N.1
Hullsiek, K.H.2
Marconi, V.3
Weintrob, A.4
Ganesan, A.5
Barthel, R.V.6
Fraser, S.7
Agan, B.K.8
Wegner, S.9
-
27
-
-
70449368710
-
HIV infection and the risk of cancers with and without a known infectious cause
-
SILVERBERG MJ, CHAO C, LEYDEN WA, XU L, TANG B, HORBERG MA, KLEIN D, QUESENBERRY CP JR, TOWNER WJ, ABRAMS DI. HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009; 23: 2337-2345.
-
(2009)
AIDS
, vol.23
, pp. 2337-2345
-
-
Silverberg, M.J.1
Chao, C.2
Leyden, W.A.3
Xu, L.4
Tang, B.5
Horberg, M.A.6
Klein, D.7
Quesenberry Jr., C.P.8
Towner, W.J.9
Abrams, D.I.10
-
28
-
-
29444459912
-
Increase in thyroid follicular cell tumor in nelfinavir-Treated rats observed in 2-Year carcinogenicity study is consistent with a rat-Specific mechanism of thyroid neoplasia
-
BURNS-NAAS LA, ZORBAS M, JESSEN B, EVERING W, STEVENS G, IVETT JL, RYAN TE, COOK JC, CAPEN CC, CHEN M, FURMAN G, THEISS JC, WEBBER S, WU E, SHETTY B, GASSER R, MCCLAIN RM. Increase in thyroid follicular cell tumor in nelfinavir-Treated rats observed in 2-Year carcinogenicity study is consistent with a rat-Specific mechanism of thyroid neoplasia. Hum Exp Toxicol 2005; 24: 643-654.
-
(2005)
Hum Exp Toxicol
, vol.24
, pp. 643-654
-
-
Burns-Naas, L.A.1
Zorbas, M.2
Jessen, B.3
Evering, W.4
Stevens, G.5
Ivett, J.L.6
Ryan, T.E.7
Cook, J.C.8
Capen, C.C.9
Chen, M.10
Furman, G.11
Theiss, J.C.12
Webber, S.13
Wu, E.14
Shetty, B.15
Gasser, R.16
Mcclain, R.M.17
-
29
-
-
8844226604
-
Cirrhosis and hepatocellular carcinoma in HIV-Infected veterans with and without the hepatitis C virus: A Cohort Study 1992-2001
-
GIORDANO TP, KRAMER JR, SOUCHEK J, RICHARDSON P, EL-SERAG HB. Cirrhosis and hepatocellular carcinoma in HIV-Infected veterans with and without the hepatitis C virus: A cohort study, 1992-2001. Arch Intern Med 2004; 164: 2349-2354.
-
(2004)
Arch Intern Med
, vol.164
, pp. 2349-2354
-
-
Giordano, T.P.1
Kramer, J.R.2
Souchek, J.3
Richardson, P.4
El-Serag, H.B.5
-
30
-
-
0034606721
-
Hepatotoxicity associate with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
-
SULKOWSKI MS, THOMAS DL, CHAISSON RE, MOORE RD. Hepatotoxicity associate with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000; 283: 74-80.
-
(2000)
JAMA
, vol.283
, pp. 74-80
-
-
Sulkowski, M.S.1
Thomas, D.L.2
Chaisson, R.E.3
Moore, R.D.4
-
31
-
-
55949086924
-
Hepatocellular carcinoma: Epidemiology, risk factors, and pathogenesis
-
GOMAA AI, KHAN SA, TOLEDANO MB, WAKED I, TAYIORROBINSON SD. Hepatocellular carcinoma: Epidemiology, risk factors, and pathogenesis. World J Gastroenterol 2008; 14: 4300-4308.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 4300-4308
-
-
Gomaa, A.I.1
Khan, S.A.2
Toledano, M.B.3
Waked, I.4
Tayiorrobinson, S.D.5
-
32
-
-
0348048808
-
Global health improvement and WHO: Shaping the future
-
JONG-WOOK L. Global health improvement and WHO: Shaping the future. Lancet 2003; 362: 2083-2088.
-
(2003)
Lancet
, vol.362
, pp. 2083-2088
-
-
Jong-Wook, L.1
-
33
-
-
0033559933
-
Estimates of the worldwide incidence of 25 major cancers in 1990
-
PARKIN DM, PISANI P, FERLAY J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1990; 80: 827-841.
-
Int J Cancer
, vol.1990
, Issue.80
, pp. 827-841
-
-
Parkin, D.M.1
Pisani, P.2
Ferlay, J.3
-
34
-
-
0036291076
-
Epidemiology, risk factors and natural history of hepatocellular carcinoma
-
MONTALTO G, CERVELLO M, GIANNITRAPANI L, DANTONA F, TERRANOVA A, CASTAGNETTA LA. Epidemiology, risk factors and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002; 963: 13-20.
-
(2002)
Ann N Y Acad Sci
, vol.963
, pp. 13-20
-
-
Montalto, G.1
Cervello, M.2
Giannitrapani, L.3
Dantona, F.4
Terranova, A.5
Castagnetta, L.A.6
-
35
-
-
84867956094
-
Globocan graphical package 1: Cancer incidence and mortality worldwide
-
FERLAY J, PARKIN DM, PISANI P. Globocan Graphical Package 1: Cancer incidence and mortality worldwide. IARC Press, Lyon, 1998.
-
(1998)
IARC Press Lyon
-
-
Ferlay, J.1
Parkin, D.M.2
Pisani, P.3
-
37
-
-
0033545541
-
Rising incidence of hepatocellular carcinoma in the United States
-
EL-SERAG HB, MASON AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
-
(1999)
N Engl J Med
, vol.340
, pp. 745-750
-
-
El-Serag, H.B.1
Mason, A.C.2
-
38
-
-
33847369349
-
Hepatocellular cancer: A guide for the internist
-
PARIKH S, HYMAN D. Hepatocellular cancer: A guide for the internist. Am J Med 2007; 120: 194-202.
-
(2007)
Am J Med
, vol.120
, pp. 194-202
-
-
Parikh, S.1
Hyman, D.2
-
39
-
-
85062055676
-
Liver-Related deaths in persons infected with the human immunodeficiency virus: The D:A:D study
-
WEBER R, SABIN CA, FRIIS-MØLLER N, REISS P, EL-SADR WM, KIRK O, DABIS F, LAW MG, PRADIER C, DE WIT S, AKERLUND B, CALVO G, MONFORTE A, RICKENBACH M, LEDERGERBER B, PHIILIPS AN, LUNDGREN JD. Liver-Related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
-
(2006)
Arch Intern Med
, vol.166
, pp. 1632-1641
-
-
Weber, R.1
Sabin, C.A.2
Friis-Møller, N.3
Reiss, P.4
El-Sadr, W.M.5
Kirk, O.6
Dabis, F.7
Law, M.G.8
Pradier, C.9
De Wit, S.10
Akerlund, B.11
Calvo, G.12
Monforte, A.13
Rickenbach, M.14
Ledergerber, B.15
Phiilips, A.N.16
Lundgren, J.D.17
-
40
-
-
33750948091
-
Hepatocellular carcinoma and non-Hodgkin's lymphoma: The roles of HIV, hepatitis C infection and alcohol abuse
-
MCGINNIS KA, FULTZ SL, SKANDERSON M, CONIGLIARO J, BRYANT K, JUSTICE AC. Hepatocellular carcinoma and non-Hodgkin's lymphoma: The roles of HIV, hepatitis C infection and alcohol abuse. J Clin Oncol 2006; 24: 5005-5009.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5005-5009
-
-
Mcginnis, K.A.1
Fultz, S.L.2
Skanderson, M.3
Conigliaro, J.4
Bryant, K.5
Justice, A.C.6
-
41
-
-
0042232018
-
Mortality due to hepatitis c-Related liver disease in HIV infected patients in France (Mortavic 2001 study
-
ROSENTHAL E, POIREE M, PRADIER C, PERRONNE C, SALMON-CERON D, GEFFRAY L, MYERS RP, MORLAT P, PIALOUX G, POI S, CACOUB P. Mortality due to hepatitis C-Related liver disease in HIV infected patients in France (Mortavic 2001 study). AIDS 2003; 17: 1803-1809.
-
(2003)
AIDS
, vol.17
, pp. 1803-1809
-
-
Rosenthal, E.1
Poiree, M.2
Pradier, C.3
Perronne, C.4
Salmon-Ceron, D.5
Geffray, L.6
Myers, R.P.7
Morlat, P.8
Pialoux, G.9
Poi, S.10
Cacoub, P.11
-
42
-
-
61749087148
-
The ANRS EN19 Mortalité Study Group and Mortavic. Emerging role of hepatocellular carcinoma among liver-Related causes of deaths in HIVinfected patients: The French national Mortalité 2005 study
-
SALMON-CERON D, ROSENTHAL E, LEWDEN C, BOUTELOUP V, MAY T, BURTY C, BONNET F, COSTAGLIOLA D, JOUGLA E, SEMAILLE C, MORLAT P, CACOUB P, CHÊNE G. The ANRS EN19 Mortalité Study Group and Mortavic. Emerging role of hepatocellular carcinoma among liver-Related causes of deaths in HIVinfected patients: The French national Mortalité 2005 study. J Hepatol 2009; 50: 736-745.
-
J Hepatol
, vol.2009
, Issue.50
, pp. 736-745
-
-
Salmon-Ceron, D.1
Rosenthal, E.2
Lewden, C.3
Bouteloup, V.4
May, T.5
Burty, C.6
Bonnet, F.7
Costagliola, D.8
Jougla, E.9
Semaille, C.10
Morlat, P.11
Cacoub, P.12
Chêne, G.13
-
43
-
-
13744255153
-
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C
-
KRAMER JR, GIORDANO TP, SOUCHEK J, RICHARDSON P, HWANG LY, EL-SERAG HB. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 2005; 100: 56-63.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 56-63
-
-
Kramer, J.R.1
Giordano, T.P.2
Souchek, J.3
Richardson, P.4
Hwang, L.Y.5
El-Serag, H.B.6
-
45
-
-
0031616255
-
Overview of the epidemiology of immunodeficiency-Associated cancers
-
BERAL V, NEWTON R. Overview of the epidemiology of immunodeficiency- Associated cancers. J Natl Cancer Inst Monogr 1998; 23: 1-6.
-
(1998)
J Natl Cancer Inst Monogr
, vol.23
, pp. 1-6
-
-
Beral, V.1
Newton, R.2
-
46
-
-
10244234049
-
Hepatocellular carcinoma in HIV-Infected patients: Epidemiological features, clinical presentation and outcome
-
PUOTI M, BRUNO R, SORIANO V, DONATO F, GAETA GB, QUINZAN GP, PRECONE D, GELATTI U, ASENSI V, VACCHER E. Hepatocellular carcinoma in HIV-Infected patients: Epidemiological features, clinical presentation and outcome. AIDS 2004; 18: 2285-2293.
-
(2004)
AIDS
, vol.18
, pp. 2285-2293
-
-
Puoti, M.1
Bruno, R.2
Soriano, V.3
Donato, F.4
Gaeta, G.B.5
Quinzan, G.P.6
Precone, D.7
Gelatti, U.8
Asensi, V.9
Vaccher, E.10
-
47
-
-
18744419424
-
A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C the study group of the association of italian hemophilia centers
-
TRADATI F, COLOMBO M, MANNUCCI P, RUMI M, DE FAZIO C, GAMBA G, CIAVARELLA N, ROCINO A, MORFINI M, SCARAGGI A, TAIOLI E. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 1998; 91: 1173-1177.
-
(1998)
Blood
, vol.91
, pp. 1173-1177
-
-
Tradati, F.1
Colombo, M.2
Mannucci, P.3
Rumi, M.4
De Fazio, C.5
Gamba, G.6
Ciavarella, N.7
Rocino, A.8
Morfini, M.9
Scaraggi, A.10
Taioli, E.11
-
48
-
-
0037445556
-
Testing, referral and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with HIV infection
-
FULTZ S, JUSTICE A, BUTT A, RABENECK L, WEISSMAN S, RODRIGUEZ-BARRADAS M. Testing, referral and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with HIV infection. Clin Infect Dis 2003; 36: 1039-1046.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 1039-1046
-
-
Fultz, S.1
Justice, A.2
Butt, A.3
Rabeneck, L.4
Weissman, S.5
Rodriguez-Barradas, M.6
-
49
-
-
30144436698
-
Management of hepatocellular carcinoma in human immunodeficiency virus-Infected patients
-
BRUNO R, PUOTI M, SACCHI P, FILICE C, CAROSI G, FILICE G. Management of hepatocellular carcinoma in human immunodeficiency virus-Infected patients. J Hepatol 2006; 44: S146-S150.
-
(2006)
J Hepatol
, vol.44
-
-
Bruno, R.1
Puoti, M.2
Sacchi, P.3
Filice, C.4
Carosi, G.5
Filice, G.6
-
50
-
-
41849120447
-
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
-
MACDONALD D, NELSON M, BOWER M, POWLES T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.World J Gastroenterol 2008; 14: 1657-1663.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 1657-1663
-
-
Macdonald, D.1
Nelson, M.2
Bower, M.3
Powles, T.4
-
51
-
-
0037087144
-
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A crosssectional analysis of the US adult AIDS Clinical Trials Group
-
SHERMAN KE, ROUSTER SD, CHUNG RT, RAJICIC N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A crosssectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34: 831-837.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 831-837
-
-
Sherman, K.E.1
Rouster, S.D.2
Chung, R.T.3
Rajicic, N.4
-
52
-
-
0037211571
-
HIV-HCV COHORT STUDY GROUP. HIV and HCV co-Infection: Situation at six French university hospitals in the year 2000
-
BUFFET-JANVRESSE C, PEIGUE-LAFEUILLE H, BENICHOU J, VABRET A, BRANGER M, TRIMOULET P, GORIA O, LAURICHESSE H, ABBED A, VERDON R, BOUVET E, LAFON ME, DUSSAIX E, CORMERAIS L, DUPON M, HENQUELL C, JOSSE A, LAGOUTTE P, LARIVEN S, LEGAC S, RIACHI G, VERDON R, VITTECOQ D; HIV-HCV COHORT STUDY GROUP. HIV and HCV co-Infection: Situation at six French university hospitals in the year 2000. J Med Virol 2003; 69: 7-17.
-
J Med Virol
, vol.2003
, Issue.69
, pp. 7-17
-
-
Buffet-Janvresse, C.1
Peigue-Lafeuille, H.2
Benichou, J.3
Vabret, A.4
Branger, M.5
Trimoulet, P.6
Goria, O.7
Laurichesse, H.8
Abbed, A.9
Verdon, R.10
Bouvet, E.11
Lafon, M.E.12
Dussaix, E.13
Cormerais, L.14
Dupon, M.15
Henquell, C.16
Josse, A.17
Lagoutte, P.18
Lariven, S.19
Legac, S.20
Riachi, G.21
Verdon, R.22
Vittecoq, D.23
more..
-
53
-
-
0036828832
-
Hepatitis C and human immunodeficiency virus infection
-
THOMAS D. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002; 36: S201-209.
-
(2002)
Hepatology
, vol.36
-
-
Thomas, D.1
-
54
-
-
20244373332
-
EuroSIDA group Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
-
KONOPNICKI D, MOCROFT A, DE WIT S, ANTUNES F, LEDERGERBER B, KATLAMA C, ZILMER K, VELLA S, KIRK O, LUNDGREN JD. EuroSIDA Group Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 593-601.
-
(2005)
AIDS
, vol.19
, pp. 593-601
-
-
Konopnicki, D.1
Mocroft, A.2
De Wit, S.3
Antunes, F.4
Ledergerber, B.5
Katlama, C.6
Zilmer, K.7
Vella, S.8
Kirk, O.9
Lundgren, J.D.10
-
55
-
-
24644443695
-
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
-
EuroSIDA Study Group.
-
ROCKSTROH JK, MOCROFT A, SORIANO V, TURAL C, LOSSO MH, HORBAN A, KIRK O, PHILLIPS A, LEDERGERBER B, LUNDGREN J. EuroSIDA Study Group. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192: 992-1002.
-
(2005)
J Infect Dis
, vol.192
, pp. 992-1002
-
-
Rockstroh, J.K.1
Mocroft, A.2
Soriano, V.3
Tural, C.4
Losso, M.H.5
Horban, A.6
Kirk, O.7
Phillips, A.8
Ledergerber, B.9
Lundgren, J.10
-
56
-
-
0037078315
-
Coinfection with hepatitis viruses and outcome of the first antiretroviral regimen in previously naive HIV-Infected subjects
-
D'ARMINIO MONFORTE A FOR THE I.CO.N.A. STUDY GROUP
-
DE LUCA A, BUGARINI R, COZZI LEPRI A, PUOTI M, GIRARDI E, ANTINORI A, POGGIO A, PAGANO G, TOSITTI G, CADEO G, MACOR A, TOTI M, D'ARMINIO MONFORTE A FOR THE I.CO.N.A. STUDY GROUP. Coinfection with hepatitis viruses and outcome of the first antiretroviral regimen in previously naive HIV-Infected subjects. Arch Intern Med 2002; 162: 2125-2132.
-
(2002)
Arch Intern Med
, vol.162
, pp. 2125-2132
-
-
De Luca, A.1
Bugarini, R.2
Cozzi Lepri, A.3
Puoti, M.4
Girardi, E.5
Antinori, A.6
Poggio, A.7
Pagano, G.8
Tositti, G.9
Cadeo, G.10
Macor, A.11
Toti, M.12
-
57
-
-
9144224875
-
Hepatitis B virus maintains its pro-Oncogenic properties in the case of occult HBV infection
-
POLLICINO T, SQUADRITO G, CERENZIA G, CACCIOLA I, RAFFA G, CRAXI A, FARINATI F, MISSALE G, SMEDILE A, TIRIBELLI C, VILLA E, RAIMONDO G. Hepatitis B virus maintains its pro-Oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126: 102-110.
-
(2004)
Gastroenterology
, vol.126
, pp. 102-110
-
-
Pollicino, T.1
Squadrito, G.2
Cerenzia, G.3
Cacciola, I.4
Raffa, G.5
Craxi, A.6
Farinati, F.7
Missale, G.8
Smedile, A.9
Tiribelli, C.10
Villa, E.11
Raimondo, G.12
-
58
-
-
0034296954
-
Occult hepatitis B virus infection in HBs antigen-Negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53
-
SHIOTA G, OYAMA K, UDAGAWA A, TANAKA K, NOMI T, KITAMURA A, TSUTSUMI A, NOGUCHI N, TAKANO Y, YASHIMA K, KISHIMOTO Y, SUOU T, KAWASAKI H. Occult hepatitis B virus infection in HBs antigen-Negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53. J Med Virol 2000; 62: 151-158.
-
(2000)
J Med Virol
, vol.62
, pp. 151-158
-
-
Shiota, G.1
Oyama, K.2
Udagawa, A.3
Tanaka, K.4
Nomi, T.5
Kitamura, A.6
Tsutsumi, A.7
Noguchi, N.8
Takano, Y.9
Yashima, K.10
Kishimoto, Y.11
Suou, T.12
Kawasaki, H.13
-
59
-
-
40949109774
-
Epidemiology of hepatocellular carcinoma in USA
-
EL-SERAG HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007; 37(2): S88-S94.
-
(2007)
Hepatol Res
, vol.37
, Issue.2
-
-
El-Serag, H.B.1
-
60
-
-
10444237187
-
Hepatocellular carcinoma
-
AHN J, FLAMM SL. Hepatocellular carcinoma. Dis Mon 2004; 50: 556-573.
-
(2004)
Dis Mon
, vol.50
, pp. 556-573
-
-
Ahn, J.1
Flamm, S.L.2
-
61
-
-
34248995566
-
Hepatitis B virus-Related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors
-
LIU CJ, KAO JH. Hepatitis B virus-Related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors. J Chin Med Assoc 2007; 70: 141-145.
-
(2007)
J Chin Med Assoc
, vol.70
, pp. 141-145
-
-
Liu, C.J.1
Kao, J.H.2
-
62
-
-
0034099208
-
Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, miogenoactivated protein kinase and JAK/STAT pathways
-
ARBUTHNOT P, CAPOVILLA A, KEW M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, miogenoactivated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 2000; 15: 357-368.
-
(2000)
J Gastroenterol Hepatol
, vol.15
, pp. 357-368
-
-
Arbuthnot, P.1
Capovilla, A.2
Kew, M.3
-
63
-
-
70449134824
-
Hepatitis B and C virusrelated carcinogenesis
-
FUNG J, LAI CL, YUEN MF. Hepatitis B and C virusrelated carcinogenesis. Clin Microbiol Infect 2009; 15: 964-970.
-
(2009)
Clin Microbiol Infect
, vol.15
, pp. 964-970
-
-
Fung, J.1
Lai, C.L.2
Yuen, M.F.3
-
64
-
-
33745517203
-
Hepatitis B virus-Related hepatocellular carcinoma: Paradigms for viral-Related human carcinogenesis
-
KREMSDORF D, SOUSSAN P, PATERLINI-BRECHOT P, BRECHOT C. Hepatitis B virus-Related hepatocellular carcinoma: Paradigms for viral-Related human carcinogenesis. Oncogene 2006; 25: 3823-3833.
-
(2006)
Oncogene
, vol.25
, pp. 3823-3833
-
-
Kremsdorf, D.1
Soussan, P.2
Paterlini-Brechot, P.3
Brechot, C.4
-
65
-
-
0028148190
-
Coinfection of hepatitis C virus in patients with chronic hepatitis B infection
-
SATO S, FUJIYAMA S, TANAKA M, YAMASAKI K, KURAMOTO I, KAWANO S, SATO T, MIZUNO K, NONAKA S. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159-166.
-
(1994)
J Hepatol
, vol.21
, pp. 159-166
-
-
Sato, S.1
Fujiyama, S.2
Tanaka, M.3
Yamasaki, K.4
Kuramoto, I.5
Kawano, S.6
Sato, T.7
Mizuno, K.8
Nonaka, S.9
-
66
-
-
53149105513
-
HIV-1 Tat and AIDSassociated cancer: Targeting the cellular anti-Cancer barrier
-
NUNNARI G, SMITH JA, DANIEL R. HIV-1 Tat and AIDSassociated cancer: Targeting the cellular anti-Cancer barrier. J Exp Clin Cancer Res 2008; 27: 3.
-
(2008)
J Exp Clin Cancer Res
, vol.27
, pp. 3
-
-
Nunnari, G.1
Smith, J.A.2
Daniel, R.3
-
67
-
-
0027371069
-
Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes
-
CORALLINI A, ALTAVILLA G, POZZI L, BIGNOZZI F, NEGRINI M, RIMESSI P, GUALANDI F, BARBANTI BRODANO G. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993; 53: 5569-5575.
-
(1993)
Cancer Res
, vol.53
, pp. 5569-5575
-
-
Corallini, A.1
Altavilla, G.2
Pozzi, L.3
Bignozzi, F.4
Negrini, M.5
Rimessi, P.6
Gualandi, F.7
Barbanti Brodano, G.8
-
68
-
-
0033810102
-
Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene
-
ALTAVILLA G, CAPUTO A, LANFREDI M, PIOLA C, BARBANTI-BRODANO G, CORALLINI A. Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol 2000; 157: 1081-1089.
-
(2000)
Am J Pathol
, vol.157
, pp. 1081-1089
-
-
Altavilla, G.1
Caputo, A.2
Lanfredi, M.3
Piola, C.4
Barbanti-Brodano, G.5
Corallini, A.6
-
69
-
-
0027424166
-
Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis
-
ZAULI G, GIBELLINI D, MILANI D, MAZZONI M, BORGATTI P, LA PLACA M, CAPITANI S. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res 1993, 53: 4481-4485.
-
(1993)
Cancer Res
, vol.53
, pp. 4481-4485
-
-
Zauli, G.1
Gibellini, D.2
Milani, D.3
Mazzoni, M.4
Borgatti, P.5
La Placa, M.6
Capitani, S.7
-
70
-
-
0029166589
-
HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis
-
CAMPIONI D, CORALLINI A, ZAULI G, POSSATI L, ALTAVILLA G, BARBANTI, BRODANO G. HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res Hum Retroviruses 1995, 11: 1039-1048.
-
(1995)
AIDS Res Hum Retroviruses
, vol.11
, pp. 1039-1048
-
-
Campioni, D.1
Corallini, A.2
Zauli, G.3
Possati, L.4
Altavilla, G.5
Barbanti Brodano, G.6
-
71
-
-
0028036878
-
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
-
ENSOLI B, GENDELMAN R, MARKHAM P, FIORELLI V, COLOMBINI S, RAFFELD M, CAFARO A, CHANG HK, BRADY J, GALLO RC. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994; 371: 674-680.
-
(1994)
Nature
, vol.371
, pp. 674-680
-
-
Ensoli, B.1
Gendelman, R.2
Markham, P.3
Fiorelli, V.4
Colombini, S.5
Raffeld, M.6
Cafaro, A.7
Chang, H.K.8
Brady, J.9
Gallo, R.C.10
-
72
-
-
0029005475
-
Tat, the human immunodeficiency virus type regulatory protein, has angiogenic properties
-
ALBINI A, BARILLARI G, BENELLI R, GALLO RC, ENSOLI B. Tat, the human immunodeficiency virus type regulatory protein, has angiogenic properties. Proc Natl Acad Sci USA 1995; 92: 4838-4842.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 4838-4842
-
-
Albini, A.1
Barillari, G.2
Benelli, R.3
Gallo, R.C.4
Ensoli, B.5
-
73
-
-
0025344596
-
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
-
ENSOLI B, BARILLARI G, SALAHAUDIN ZS, GALLO RC, WONG-STAAL F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990; 345: 84-86.
-
(1990)
Nature
, vol.345
, pp. 84-86
-
-
Ensoli, B.1
Barillari, G.2
Salahaudin, Z.S.3
Gallo, R.C.4
Wong-Staal, F.5
-
74
-
-
0027955428
-
The expression of the interleukin 6 gene induced by the human immunodeficiency virus type 1 Tat protein
-
SCALA G, RUOCCO MR, AMBROSINO C, MALLARDO M, GIORDANO V, BALDASSARE F, DRAGONETTI E, QUINTO I, VENUTA S. The expression of the interleukin 6 gene induced by the human immunodeficiency virus type 1 Tat protein. J Exp Med 1994; 179: 961-971.
-
(1994)
J Exp Med
, vol.179
, pp. 961-971
-
-
Scala, G.1
Ruocco, M.R.2
Ambrosino, C.3
Mallardo, M.4
Giordano, V.5
Baldassare, F.6
Dragonetti, E.7
Quinto, I.8
Venuta, S.9
-
75
-
-
0028271114
-
Human immunodeficiency virus type 1 upregulates interleukin secretion in activated T cells
-
WESTENDORP MO, LI-WEBER M, FRANK RW, KRAMMER PH. Human immunodeficiency virus type 1 upregulates interleukin secretion in activated T cells. J Virol 1994; 68: 4177-4185.
-
(1994)
J Virol
, vol.68
, pp. 4177-4185
-
-
Westendorp, M.O.1
Li-Weber, M.2
Frank, R.W.3
Krammer, P.H.4
-
76
-
-
0029940987
-
Activation of transcription factor NF-KB by the Tat protein of human immunodeficiency virus type-1
-
DE MARCHI F, D'ADDA DI FAGAGNA F, FALASCHI A, GIACCA M. Activation of transcription factor NF-KB by the Tat protein of human immunodeficiency virus type-1. J Virol 1996; 70: 4427-4437.
-
(1996)
J Virol
, vol.70
, pp. 4427-4437
-
-
De Marchi, F.1
D'adda Di Fagagna, F.2
Falaschi, A.3
Giacca, M.4
-
77
-
-
43949129075
-
Impact of HIV on host-Virus interactions during early hepatitis C virus infection
-
DANTA M, SEMMO N, FABRIS P, BROWN D, PYBUS OG, SABIN CA, BHAGANI S, EMERY VC, DUSHEIKO GM, KLENERMAN P. Impact of HIV on host-Virus interactions during early hepatitis C virus infection. J Infect Dis 2008; 197: 1558-1566.
-
(2008)
J Infect Dis
, vol.197
, pp. 1558-1566
-
-
Danta, M.1
Semmo, N.2
Fabris, P.3
Brown, D.4
Pybus, O.G.5
Sabin, C.A.6
Bhagani, S.7
Emery, V.C.8
Dusheiko, G.M.9
Klenerman, P.10
-
78
-
-
47349112672
-
Acute HCV in HIV-Positive individuals-A review
-
DANTA M, DUSHEIKO GM. Acute HCV in HIV-Positive individuals-A review. Curr Pharm Des 2008; 14: 1690-1697.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 1690-1697
-
-
Danta, M.1
Dusheiko, G.M.2
-
79
-
-
0036736542
-
Hepatitis viruses and hepatocellular carcinoma in HIV-Infected patients
-
SMUKLER AJ, RATNER L. Hepatitis viruses and hepatocellular carcinoma in HIV-Infected patients. Curr Opin Oncol 2002; 14: 538-542.
-
(2002)
Curr Opin Oncol
, vol.14
, pp. 538-542
-
-
Smukler, A.J.1
Ratner, L.2
-
80
-
-
0036841848
-
High prevalence of metabolic syndrome among HIV-Infected patients: Link with the cardiovascular risk
-
BRUNO R, GAZZARUSO C, SACCHI P, ZOCCHETTI C, GIORDANETTI S, GARZANITI A, CIAPPINA V, MAFFEZZINI E, MASERATI R, FILICE G. High prevalence of metabolic syndrome among HIV-Infected patients: Link with the cardiovascular risk. J Acquir Immune Defic Syndr 2002; 31: 363-365.
-
(2002)
J Acquir Immune Defic Syndr
, vol.31
, pp. 363-365
-
-
Bruno, R.1
Gazzaruso, C.2
Sacchi, P.3
Zocchetti, C.4
Giordanetti, S.5
Garzaniti, A.6
Ciappina, V.7
Maffezzini, E.8
Maserati, R.9
Filice, G.10
-
81
-
-
0035882187
-
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A metaanalysis
-
GRAHAM CS, BADEN LR, YU E, MRUS JM, CARNIE J, HEEREN T, KOZIEL MJ. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A metaanalysis. Clin Infect Dis 2001; 33: 562-569.
-
(2001)
Clin Infect Dis
, vol.33
, pp. 562-569
-
-
Graham, C.S.1
Baden, L.R.2
Yu, E.3
Mrus, J.M.4
Carnie, J.5
Heeren, T.6
Koziel, M.J.7
-
82
-
-
0032837102
-
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
-
BENHAMOU Y, BOCHET M, DI MARTINO V, CHARLOTTE F, AZRIA F, COUTELLIER A, VIDAUD M, BRICAIRE F, OPOLON P, KATLAMA C, POYNARD T. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30: 1054-1058.
-
(1999)
The Multivirc Group. Hepatology
, vol.30
, pp. 1054-1058
-
-
Benhamou, Y.1
Bochet, M.2
Di Martino, V.3
Charlotte, F.4
Azria, F.5
Coutellier, A.6
Vidaud, M.7
Bricaire, F.8
Opolon, P.9
Katlama, C.10
Poynard, T.11
-
83
-
-
77950814587
-
Gp120 modulates the biology of human hepatic stellate cells: A link between HIV infection and liver fibrogenesis
-
BRUNO R, GALASTRI S, SACCHI P, CIMA S, CALIGIURI A, DEFRANCO R, MILANI S, GESSANI S, FANTUZZI L, LIOTTA F, FROSALI F, ANTONUCCI G, PINZANI M, MARRA F. Gp120 modulates the biology of human hepatic stellate cells: A link between HIV infection and liver fibrogenesis. Gut 2010; 59(4): 513-520.
-
(2010)
Gut
, vol.59
, Issue.4
, pp. 513-520
-
-
Bruno, R.1
Galastri, S.2
Sacchi, P.3
Cima, S.4
Caligiuri, A.5
Defranco, R.6
Milani, S.7
Gessani, S.8
Fantuzzi, L.9
Liotta, F.10
Frosali, F.11
Antonucci, G.12
Pinzani, M.13
Marra, F.14
-
84
-
-
84864280100
-
HIV induces TRAIL sensitivity in hepatocytes
-
BABU CK, SUWANSRINON K, BREN GD, BADLEY AD, RIZZA SA. HIV induces TRAIL sensitivity in hepatocytes. PLoS ONE 2009; 4: E4623.
-
(2009)
PLoS ONE
, vol.4
-
-
Babu, C.K.1
Suwansrinon, K.2
Bren, G.D.3
Badley, A.D.4
Rizza, S.A.5
-
85
-
-
0342618506
-
Severe hepatitis in three AIDS patients treated with indinavir
-
BRAU N, LEAF HL, WIECZOREK RL, MARGOLIS DM. Severe hepatitis in three AIDS patients treated with indinavir. Lancet 1997; 349: 924-925.
-
(1997)
Lancet
, vol.349
, pp. 924-925
-
-
Brau, N.1
Leaf, H.L.2
Wieczorek, R.L.3
Margolis, D.M.4
-
86
-
-
0032898237
-
Natural history of untreated non surgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
-
LLOVET JM, BUSTAMANTE J, CASTELLS A, VILANA R, AYUSO MDEL C, SALA M, BRÙ C, RODÈS J, BRUIX J. Natural history of untreated non surgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-67.
-
(1999)
Hepatology
, vol.29
, pp. 62-67
-
-
Llovet, J.M.1
Bustamante, J.2
Castells, A.3
Vilana, R.4
Ayuso Mdel, C.5
Sala, M.6
Brù, C.7
Rodès, J.8
Bruix, J.9
-
87
-
-
0022641586
-
Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis A study in 22 patients
-
EBARA M, OHTO M, SHINAGAWA T, SUGIURA N, KIMURA K, MATSUTANI S, MORITA M, SAISHO H, TSUCHIYA Y, OKUDA K. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986; 90: 289-298.
-
(1986)
Gastroenterology
, vol.90
, pp. 289-298
-
-
Ebara, M.1
Ohto, M.2
Shinagawa, T.3
Sugiura, N.4
Kimura, K.5
Matsutani, S.6
Morita, M.7
Saisho, H.8
Tsuchiya, Y.9
Okuda, K.10
-
88
-
-
0026778304
-
Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival
-
BARBARA L, BENZI G, GAIANI S, FUSCONI F, ZIRONI G, SIRINGO S, RIGAMONTI A, BARBARA C, GRIGIONI W, MAZZIOTTI A. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-137.
-
(1992)
Hepatology
, vol.16
, pp. 132-137
-
-
Barbara, L.1
Benzi, G.2
Gaiani, S.3
Fusconi, F.4
Zironi, G.5
Siringo, S.6
Rigamonti, A.7
Barbara, C.8
Grigioni, W.9
Mazziotti, A.10
-
89
-
-
0024333723
-
Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time A preliminary report
-
OKAZAKI N, YOSHINO M, YOSHIDA T, SUZUKI M, MORIYAMA N, TAKAYASU K, MAKUUCHI M, YAMAZAKI S, HASEGAWA H, NOGUCHI M. Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report. Cancer 1989; 63: 2207-2210.
-
(1989)
Cancer
, vol.63
, pp. 2207-2210
-
-
Okazaki, N.1
Yoshino, M.2
Yoshida, T.3
Suzuki, M.4
Moriyama, N.5
Takayasu, K.6
Makuuchi, M.7
Yamazaki, S.8
Hasegawa, H.9
Noguchi, M.10
-
90
-
-
0035160949
-
Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development
-
BENVEGNÙ L, NOVENTA F, BERNARDINELLO E, PONTISSO P, GATTA A, ALBERTI A. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut 2001; 48: 110-115.
-
(2001)
Gut
, vol.48
, pp. 110-115
-
-
Benvegnù, L.1
Noventa, F.2
Bernardinello, E.3
Pontisso, P.4
Gatta, A.5
Alberti, A.6
-
91
-
-
0036742628
-
Epidemiology and clinical presentation of hepatocellular carcinoma
-
DI BISCEGLIE AM. Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13: S169-S171.
-
(2002)
J Vasc Interv Radiol
, vol.13
-
-
Di Bisceglie, A.M.1
-
92
-
-
0030697246
-
Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: A pilot study
-
WEINIG M, HAKIM J, GUDZA I, TOBAIWA O. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: A pilot study. Trans R Soc Trop Med Hyg 1997; 91: 570-572.
-
(1997)
Trans R Soc Trop Med Hyg
, vol.91
, pp. 570-572
-
-
Weinig, M.1
Hakim, J.2
Gudza, I.3
Tobaiwa, O.4
-
93
-
-
0037103528
-
Hepatocellular carcinoma in HIV-Infected patients with chronic hepatitis: An emerging issue
-
BRUNO R, SACCHI P, FILICE C, PUOTI M, FILICE G. Hepatocellular carcinoma in HIV-Infected patients with chronic hepatitis: An emerging issue. J Acquir Immune Defic Syndr 2002; 30: 535-536.
-
(2002)
J Acquir Immune Defic Syndr
, vol.30
, pp. 535-536
-
-
Bruno, R.1
Sacchi, P.2
Filice, C.3
Puoti, M.4
Filice, G.5
-
94
-
-
0035139215
-
Hepatocellular carcinoma in HIV-Infected patients with chronic hepatitis C
-
GARCIA-SAMANIEGO J, RODRIGUEZ M, BERENGUER J, RODRIGUEZ-ROSADO R, CARBO J, ASENSI V, SORIANO V. Hepatocellular carcinoma in HIV-Infected patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 179-183.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 179-183
-
-
Garcia-Samaniego, J.1
Rodriguez, M.2
Berenguer, J.3
Rodriguez-Rosado, R.4
Carbo, J.5
Asensi, V.6
Soriano, V.7
-
95
-
-
0034574687
-
Opportunistic infections in the liver of HIV-Infected patients in Thailand: A necropsy study
-
VIRIYAVEJAKUL P, ROJANASUNAN P, VIRIYAVEJAKUL A, PUNYARIT P, PUNPOOWONG B, KHACHANSAKSUMET V, RIGANTI M, PONGPONRATN E. Opportunistic infections in the liver of HIV-Infected patients in Thailand: A necropsy study. Southeast Asian J Trop Med Public Health 2000; 31: 663-667.
-
(2000)
Southeast Asian J Trop Med Public Health
, vol.31
, pp. 663-667
-
-
Viriyavejakul, P.1
Rojanasunan, P.2
Viriyavejakul, A.3
Punyarit, P.4
Punpoowong, B.5
Khachansaksumet, V.6
Riganti, M.7
Pongponratn, E.8
-
96
-
-
34548331766
-
Presentation and outcome of hepatocellular carcinoma in HIV infected patients: A U.S.-Canadian multicenter study
-
Nor th American Liver Cancer in HIV Study Group
-
BRÄU N, FOX RK, XIAO P, MARKS K, NAGVI Z, TAYLOR LE, TRIKHA A, SHERMAN M, SULKOWSKI MS, DIETERICH DT, RIGSBY MO, WRIGHT TL, HERNANDEZ MD, JAIN MK, KHATRI GK, STERLING RK, BONACINI M, MARTYN CA, AYTAMAN A, LLOVET JM, BROWN ST, BINI EJ. Nor th American Liver Cancer in HIV Study Group. Presentation and outcome of hepatocellular carcinoma in HIV infected patients: A U.S.-Canadian multicenter study. J Hepatol 2007; 47: 527-537.
-
(2007)
J Hepatol
, vol.47
, pp. 527-537
-
-
Bräu, N.1
Fox, R.K.2
Xiao, P.3
Marks, K.4
Nagvi, Z.5
Taylor, L.E.6
Trikha, A.7
Sherman, M.8
Sulkowski, M.S.9
Dieterich, D.T.10
Rigsby, M.O.11
Wright, T.L.12
Hernandez, M.D.13
Jain, M.K.14
Khatri, G.K.15
Sterling, R.K.16
Bonacini, M.17
Martyn, C.A.18
Aytaman, A.19
Llovet, J.M.20
Brown, S.T.21
Bini, E.J.22
more..
-
97
-
-
80053187997
-
Hepatocellular carcinoma in HIV-Infected patients: Check early, treat hard
-
BERRETTA M, GARLASSI E, CACOPARDO B, CAPPELLANI A, GUARALDI G, COCCHI S, DE PAOLI P, LLESHI A, IZZI I, TORRESIN A, DI GANGI P, PIETRANGELO A, FERRARI M, BEARZ A, BERRETTA S, NASTI G, DI BENEDETTO F, BALESTRERI L, TIRELLI U, VENTURA P. Hepatocellular carcinoma in HIV-Infected patients: Check early, treat hard. Oncologist 2011; 16: 1258-1269.
-
(2011)
Oncologist
, vol.16
, pp. 1258-1269
-
-
Berretta, M.1
Garlassi, E.2
Cacopardo, B.3
Cappellani, A.4
Guaraldi, G.5
Cocchi, S.6
De Paoli, P.7
Lleshi, A.8
Izzi, I.9
Torresin, A.10
Di Gangi, P.11
Pietrangelo, A.12
Ferrari, M.13
Bearz, A.14
Berretta, S.15
Nasti, G.16
Di Benedetto, F.17
Balestreri, L.18
Tirelli, U.19
Ventura, P.20
more..
-
98
-
-
7044239399
-
Hepatocellular carcinoma: Current management and future trends
-
CARR BI. Hepatocellular carcinoma: Current management and future trends. Gastroenterology 2004; 127: S218-S224.
-
(2004)
Gastroenterology
, vol.127
-
-
Carr, B.I.1
-
99
-
-
0028578204
-
Treatment of nonresectable hepatocellular carcinoma: Review of the literature and meta-Analysis
-
MALAGUARNERA M, TROVATO G, RESTUCCIA S, GIUGNO I, FRANZÉ CM, RECEPUTO G, SICILIANO R, MOTTA M, TROVATO BA. Treatment of nonresectable hepatocellular carcinoma: Review of the literature and meta-Analysis. Adv Ther 1994; 11: 303-319.
-
(1994)
Adv Ther
, vol.11
, pp. 303-319
-
-
Malaguarnera, M.1
Trovato, G.2
Restuccia, S.3
Giugno, I.4
Franzé, C.M.5
Receputo, G.6
Siciliano, R.7
Motta, M.8
Trovato, B.A.9
-
100
-
-
0025891345
-
Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
-
RINGE B, PICHLMAYR R, WITTEKIND C, TUSCH G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients.World J Surg 1991; 15: 270-285.
-
(1991)
World J Surg
, vol.15
, pp. 270-285
-
-
Ringe, B.1
Pichlmayr, R.2
Wittekind, C.3
Tusch, G.4
-
101
-
-
0026378112
-
Hepatic resection versus transplantation for hepatocellular carcinoma
-
IWATSUKI S, STARZL TE, SHEAHAN DG, YOKOYAMA I, DEMETRIS AJ, TODO S, TZAKIS AG, VAN THIEL DH, CARR B, SELBY R. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221-229.
-
(1991)
Ann Surg
, vol.214
, pp. 221-229
-
-
Iwatsuki, S.1
Starzl, T.E.2
Sheahan, D.G.3
Yokoyama, I.4
Demetris, A.J.5
Todo, S.6
Tzakis, A.G.7
Van Thiel, D.H.8
Carr, B.9
Selby, R.10
-
102
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
MAZZAFERRO V, REGALIA E, DOCI R, ANDREOLA S, PULVIRENTI A, BOZZETTI F, MONTALTO F, AMMATUNA M, MORABITO A, GENNARI L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
-
(1996)
N Engl J Med
, vol.334
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
Montalto, F.7
Ammatuna, M.8
Morabito, A.9
Gennari, L.10
-
103
-
-
0034856294
-
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
-
BRUIX J, SHERMAN M, LLOVET JM, BEAUGRAND M, LENCIONI R, BURROUGHS AK, CHRISTENSEN E, PAGLIARO L, COLOMBO M, RODES J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.
-
(2001)
J Hepatol
, vol.35
, pp. 421-430
-
-
Bruix, J.1
Sherman, M.2
Llovet, J.M.3
Beaugrand, M.4
Lencioni, R.5
Burroughs, A.K.6
Christensen, E.7
Pagliaro, L.8
Colombo, M.9
Rodes, J.10
-
104
-
-
44449085884
-
Design and endpoints of clinical trials in hepatocellular carcinoma
-
PANEL OF EXPERTS IN HCC-DESIGN CLINICAL TRIALS
-
LLOVET JM, DI BISCEGLIE AM, BRUIX J, KRAMER BS, LENCIONI R, ZHU AX, SHERMAN M, SCHWARTZ M, LOTZE M, TALWALKAR J, GORES GJ; PANEL OF EXPERTS IN HCC-DESIGN CLINICAL TRIALS. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 698-711.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 698-711
-
-
Llovet, J.M.1
Di Bisceglie, A.M.2
Bruix, J.3
Kramer, B.S.4
Lencioni, R.5
Zhu, A.X.6
Sherman, M.7
Schwartz, M.8
Lotze, M.9
Talwalkar, J.10
Gores, G.J.11
-
106
-
-
17744383359
-
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by varial oestrogen receptors
-
VILLA E, FERRETTI I, GROTTOLA A, BUTTAFOCO P, BUONO MG, GIANNINI F, MANNO M, BERTANI H, DUGANI A, MANENTI F. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by varial oestrogen receptors. Br J Cancer 2001; 84: 881-885.
-
(2001)
Br J Cancer
, vol.84
, pp. 881-885
-
-
Villa, E.1
Ferretti, I.2
Grottola, A.3
Buttafoco, P.4
Buono, M.G.5
Giannini, F.6
Manno, M.7
Bertani, H.8
Dugani, A.9
Manenti, F.10
-
107
-
-
0031474934
-
Influence of preoperative transarterial lipiodol chemoembolization on resection or transplantation for and hepatocellular carcinoma in patients with cirrhosis
-
MAJNO PE, ADAM R, BISMUTH H, CASTAING D, ARICHE A, KRISSAT J, PERRIN H, AZOULAY D. Influence of preoperative transarterial lipiodol chemoembolization on resection or transplantation for and hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-703.
-
(1997)
Ann Surg
, vol.226
, pp. 688-703
-
-
Majno, P.E.1
Adam, R.2
Bismuth, H.3
Castaing, D.4
Ariche, A.5
Krissat, J.6
Perrin, H.7
Azoulay, D.8
-
108
-
-
50949122441
-
Systemic therapy for hepatocellular carcinoma
-
THOMAS MB. Systemic therapy for hepatocellular carcinoma. Cancer J 2008; 14: 123-127.
-
(2008)
Cancer J
, vol.14
, pp. 123-127
-
-
Thomas, M.B.1
-
109
-
-
47949116252
-
FOR THE SHARP INVESTIGATORS STUDY GROUP. Sorafenib in advanced hepatocellular carcinoma
-
LLOVET JM, RICCI S, MAZZAFERRO V, HILGARD P, GANE E, BLANC JF, COSME A, SANTORO A, RAOUL JL, FORNER A, SCHWARTZ M, PORTA C, ZEUZEM S, BOLONDI L, GRETEN T, GALLE P, SEITZ JF, BORBATH I, HÄUSSINGER D, GIANNARIS T, SHAN M, MOSCOVICI M, VOLIOTIS D AND BRUIX J, FOR THE SHARP INVESTIGATORS STUDY GROUP. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
Cosme, A.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
Schwartz, M.11
Porta, C.12
Zeuzem, S.13
Bolondi, L.14
Greten, T.15
Galle, P.16
Seitz, J.F.17
Borbath, I.18
Häussinger, D.19
Giannaris, T.20
Shan, M.21
Moscovici, M.22
Voliotis, D.23
Bruix, J.24
more..
-
110
-
-
84655164259
-
Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART? A case report
-
(Epub ahead of print
-
CHELIS L, NTINOS N, SOUFTAS V, DEFTEREOS S, XENIDIS N, CHAMALIDOU E, MALTEZOS E, KAKOLYRIS S. Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART? A case report. Med Oncol 2010. (Epub ahead of print
-
(2010)
Med Oncol
-
-
Chelis, L.1
Ntinos, N.2
Souftas, V.3
Deftereos, S.4
Xenidis, N.5
Chamalidou, E.6
Maltezos, E.7
Kakolyris, S.8
-
111
-
-
77649163829
-
Sorafenib therapy for hepatocellular carcinoma in an HIVHCV coinfected patient: A case report
-
PERBONI G, COSTA P, FIBBIA GC, MORANDINI B, SCALZINI A, TAGLIANI A, CENGARLE R, AITINI E. Sorafenib therapy for hepatocellular carcinoma in an HIVHCV coinfected patient: A case report. Oncologist 2010; 15: 142-145.
-
(2010)
Oncologist
, vol.15
, pp. 142-145
-
-
Perboni, G.1
Costa, P.2
Fibbia, G.C.3
Morandini, B.4
Scalzini, A.5
Tagliani, A.6
Cengarle, R.7
Aitini, E.8
-
112
-
-
67649946279
-
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: A phase II study
-
ZHU A, SAHANI D, DI TOMASO E, ANCUKIEWICZ M, CATALANO OA, SINDHWANI V, BLASZKOWSKY LS, YOON SS, LAHDENRANTA J, BHARGAVA P, MEYERHARDT J, CLARK JW, KWAK EL, HEZEL AF, MIKSAD R, ABRAMS TA, ENZINGER PC, FUCHS CS, RYAN DP, JAIN RK. Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: A phase II study. J Clin Oncol 2009; 27: 3027-3035.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3027-3035
-
-
Zhu, A.1
Sahani, D.2
Di Tomaso, E.3
Ancukiewicz, M.4
Catalano, O.A.5
Sindhwani, V.6
Blaszkowsky, L.S.7
Yoon, S.S.8
Lahdenranta, J.9
Bhargava, P.10
Meyerhardt, J.11
Clark, J.W.12
Kwak, E.L.13
Hezel, A.F.14
Miksad, R.15
Abrams, T.A.16
Enzinger, P.C.17
Fuchs, C.S.18
Ryan, D.P.19
Jain, R.K.20
more..
-
113
-
-
60849124241
-
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma
-
THOMAS MB, MORRIS JS, CHADHA R, IWASAKI M, KAUR H, LIN E, KASEB A, GLOVER K, DAVILA M, ABBRUZZESE J. Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol 2009; 27: 843-850.
-
(2009)
J Clin Oncol
, vol.27
, pp. 843-850
-
-
Thomas, M.B.1
Morris, J.S.2
Chadha, R.3
Iwasaki, M.4
Kaur, H.5
Lin, E.6
Kaseb, A.7
Glover, K.8
Davila, M.9
Abbruzzese, J.10
-
114
-
-
40149098824
-
Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
-
RIZELL M, ANDERSSON M, CAHLIN C, HAFSTRÖM L, OLAUSSON M, LINDNÉR P. Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer. Int J Clin Oncol 2008; 13: 66-70.
-
(2008)
Int J Clin Oncol
, vol.13
, pp. 66-70
-
-
Rizell, M.1
Andersson, M.2
Cahlin, C.3
Hafström, L.4
Olausson, M.5
Lindnér, P.6
-
115
-
-
0029127746
-
Treatment of hepatocellular carcinoma with tamoxifen: A double-Blind placebo-Controlled trial in 120 patients
-
CASTELLS A, BRUIX J, BRÚ C, AYUSO C, ROCA M, BOIX L, VILANA R, RODÉS J. Treatment of hepatocellular carcinoma with tamoxifen: A double-Blind placebo-Controlled trial in 120 patients. Gastroenterology 1995; 109: 917-922.
-
(1995)
Gastroenterology
, vol.109
, pp. 917-922
-
-
Castells, A.1
Bruix, J.2
Brú, C.3
Ayuso, C.4
Roca, M.5
Boix, L.6
Vilana, R.7
Rodés, J.8
-
116
-
-
0033988010
-
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: A prospective randomized study
-
LIU CL, FAN ST, NG IO, LO CM, POON RT, WONG J. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: A prospective randomized study. Am J Gastroenterol 2000; 95: 218-222.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 218-222
-
-
Liu, C.L.1
Fan, S.T.2
Ng, I.O.3
Lo, C.M.4
Poon, R.T.5
Wong, J.6
-
117
-
-
0036830308
-
High-Dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial
-
ASIAN-PACIFIC HEPATOCELLULAR CARCINOMA TRIALS GROUP
-
CHOW PK, TAI BC, TAN CK, MACHIN D, WIN KM, JOHNSON PJ, SOO KC; ASIAN-PACIFIC HEPATOCELLULAR CARCINOMA TRIALS GROUP. High-Dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology 2002; 36: 1221-1226.
-
(2002)
Hepatology
, vol.36
, pp. 1221-1226
-
-
Chow, P.K.1
Tai, B.C.2
Tan, C.K.3
Machin, D.4
Win, K.M.5
Johnson, P.J.6
Soo, K.C.7
-
119
-
-
40749132136
-
Hepatocellular carcinoma in HIV patients treated by liver transplantation
-
DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, BALLARIN R, CODELUPPI M, GUARALDI G, GERUNDA GE. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol 2008; 34: 422-427.
-
(2008)
Eur J Surg Oncol
, vol.34
, pp. 422-427
-
-
Di Benedetto, F.1
De Ruvo, N.2
Berretta, M.3
Masetti, M.4
Montalti, R.5
Di Sandro, S.6
Ballarin, R.7
Codeluppi, M.8
Guaraldi, G.9
Gerunda, G.E.10
-
120
-
-
33646556679
-
Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era
-
DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, QUINTINI C, CODELUPPI M, TIRELLI U, GERUNDA GE. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol 2006; 24: E26-27.
-
(2006)
J Clin Oncol
, vol.24
-
-
Di Benedetto, F.1
De Ruvo, N.2
Berretta, M.3
Masetti, M.4
Montalti, R.5
Di Sandro, S.6
Quintini, C.7
Codeluppi, M.8
Tirelli, U.9
Gerunda, G.E.10
-
121
-
-
48049084797
-
Human immunodeficiency virus and liver transplantation: Our point of view
-
DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MONTALTI R, GUERRINI GP, BALLARIN R, DE BLASIIS MG, SPAGGIARI M, SMERIERI N, IEMMOLO RM, GUARALDI G, GERUNDA GE. Human immunodeficiency virus and liver transplantation: Our point of view. Transplant Proc 2008; 40: 1965-1971.
-
(2008)
Transplant Proc
, vol.40
, pp. 1965-1971
-
-
Di Benedetto, F.1
Di Sandro, S.2
De Ruvo, N.3
Berretta, M.4
Montalti, R.5
Guerrini, G.P.6
Ballarin, R.7
De Blasiis, M.G.8
Spaggiari, M.9
Smerieri, N.10
Iemmolo, R.M.11
Guaraldi, G.12
Gerunda, G.E.13
-
122
-
-
40749132136
-
Hepatocellular carcinoma in HIV patients treated by liver transplantation
-
DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, BALLARIN R, CODELUPPI M, GUARALDI G, GERUNDA GE. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol 2008; 34: 422-427.
-
(2008)
Eur J Surg Oncol
, vol.34
, pp. 422-427
-
-
Di Benedetto, F.1
De Ruvo, N.2
Berretta, M.3
Masetti, M.4
Montalti, R.5
Di Sandro, S.6
Ballarin, R.7
Codeluppi, M.8
Guaraldi, G.9
Gerunda, G.E.10
-
123
-
-
12644304864
-
Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma
-
KUMADA T, NAKANO S, TAKEDA I, SUGIYAMA K, OSADA T, KIRIYAMA S, SONE Y, TOYODA H, SHIMADA S, TAKAHASHI M, SASSA T. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25: 87-92.
-
(1997)
Hepatology
, vol.25
, pp. 87-92
-
-
Kumada, T.1
Nakano, S.2
Takeda, I.3
Sugiyama, K.4
Osada, T.5
Kiriyama, S.6
Sone, Y.7
Toyoda, H.8
Shimada, S.9
Takahashi, M.10
Sassa, T.11
-
124
-
-
83555174312
-
Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy?
-
DI BENEDETTO F, BERRETTA M, DE RUVO N, TARANTINO G, D'AMICO G, BALLARIN R, IEMMOLO RM, GERUNDA GE. Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy? J Surg Oncol 2012; 105: 111-112.
-
J Surg Oncol
, vol.2012
, Issue.105
, pp. 111-112
-
-
Di Benedetto, F.1
Berretta, M.2
De Ruvo, N.3
Tarantino, G.4
D'amico, G.5
Ballarin, R.6
Iemmolo, R.M.7
Gerunda, G.E.8
-
125
-
-
35748951286
-
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients
-
FRASSETTO LA, BROWNE M, CHENG A, WOLFE AR, ROLAND ME, STOCK PG, CARISON L, BENET LZ. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 2007; 7: 2816-2820.
-
(2007)
Am J Transplant
, vol.7
, pp. 2816-2820
-
-
Frassetto, L.A.1
Browne, M.2
Cheng, A.3
Wolfe, A.R.4
Roland, M.E.5
Stock, P.G.6
Carison, L.7
Benet, L.Z.8
-
126
-
-
79953310741
-
HIV-Infected patients and liver transplantation: Who, when and why
-
TAVIO M, GROSSI P, BACCARANI U, SCUDELLER L, PEA F, BERRETTA M, ADANI G,VIVARELLI M, RIVA A, TIRELLI U, BRESADOLA V, VIALE P, RISALITI A. HIV-Infected patients and liver transplantation: Who, when and why. Curr HIV Res 2011; 9: 120-127.
-
(2011)
Curr HIV Res
, vol.9
, pp. 120-127
-
-
Tavio, M.1
Grossi, P.2
Baccarani, U.3
Scudeller, L.4
Pea, F.5
Berretta, M.6
Adani Gvivarelli, M.7
Riva, A.8
Tirelli, U.9
Bresadola, V.10
Viale, P.11
Risaliti, A.12
-
127
-
-
77957892168
-
Serum markers of hepatocellular carcinoma
-
MALAGUARNERA G, GIORDANO M, PALADINA I, BERRETTA M, CAPPELLANI A, MALAGUARNERA M. Serum markers of hepatocellular carcinoma. Dig Dis Sci 2010; 55: 2744-2755.
-
(2010)
Dig Dis Sci
, vol.55
, pp. 2744-2755
-
-
Malaguarnera, G.1
Giordano, M.2
Paladina, I.3
Berretta, M.4
Cappellani, A.5
Malaguarnera, M.6
-
128
-
-
0035960609
-
Liver transplantation in adults coinfected with HIV
-
PRACHIALIAS AA, POZNIAK A, TAYLOR C, SRINIVASAN P, MUIESAN P, WENDON J, CRAMP M, WILLIAMS R, O'GRADY J, RELA M, HEATON ND. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72: 1684-1688.
-
(2001)
Transplantation
, vol.72
, pp. 1684-1688
-
-
Prachialias, A.A.1
Pozniak, A.2
Taylor, C.3
Srinivasan, P.4
Muiesan, P.5
Wendon, J.6
Cramp, M.7
Williams, R.8
O'grady, J.9
Rela, M.10
Heaton, N.D.11
-
129
-
-
0038350042
-
Multicenter study of human immunodeficiency virus-Related germ cell tumors
-
POWLES T, BOWER M, DAUGAARD G, SHAMASH J, DE RUITER A, JOHNSON M, FISHER M, ANDERSON J, MANDALIA S, STEBBING J, NELSON M, GAZZARD B, OLIVER T. Multicenter study of human immunodeficiency virus-Related germ cell tumors. J Clin Oncol 2003; 21: 1922-1927.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1922-1927
-
-
Powles, T.1
Bower, M.2
Daugaard, G.3
Shamash, J.4
De Ruiter, A.5
Johnson, M.6
Fisher, M.7
Anderson, J.8
Mandalia, S.9
Stebbing, J.10
Nelson, M.11
Gazzard, B.12
Oliver, T.13
-
130
-
-
33645088415
-
Treatment of Hepatitis C in HIV-Coinfected patients
-
HUGHES CA, SHAFRAN SD. Treatment of Hepatitis C in HIV-Coinfected patients. Ann Pharmacother 2006; 40: 479-489.
-
(2006)
Ann Pharmacother
, vol.40
, pp. 479-489
-
-
Hughes, C.A.1
Shafran, S.D.2
-
131
-
-
34548055861
-
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-Infected patients
-
LABARGA P, SORIANO V, VISPO ME, PINILLA J, MARTIN-CARBONERO L, CASTELLARES C, CASADO R, MAIDA I, GARCIA-GASCO P, BARREIRO P. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-Infected patients. J Infect Dis 2007; 196: 670-676.
-
(2007)
J Infect Dis
, vol.196
, pp. 670-676
-
-
Labarga, P.1
Soriano, V.2
Vispo, M.E.3
Pinilla, J.4
Martin-Carbonero, L.5
Castellares, C.6
Casado, R.7
Maida, I.8
Garcia-Gasco, P.9
Barreiro, P.10
-
132
-
-
34547934022
-
Rate of cirrosis progression reduced in HIV/HCV co-Infected non-Responders to anti-HCV therapy
-
DE BONA A, GALLI L, GAILOTTA G, GUZZO A, ALAGNA L, LAZZARIN A, UBERTI-FOPPA C. Rate of cirrosis progression reduced in HIV/HCV co-Infected non-Responders to anti-HCV therapy. New Microbiol 2007; 30: 259-264.
-
(2007)
New Microbiol
, vol.30
, pp. 259-264
-
-
De Bona, A.1
Galli, L.2
Gailotta, G.3
Guzzo, A.4
Alagna, L.5
Lazzarin, A.6
Uberti-Foppa, C.7
-
133
-
-
19244364599
-
Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus
-
SORIANO V, GARCIA-SAMANIEGO J, BRAVO R, GONZALEZ J, CASTRO A, CASTILLA J, MARTÍNEZ-ODRIOZOLA P, COLMENERO M, CARBALLO E, SUÁREZ D, RODRÍGUEZPIÑERO FJ, MORENO A, DEL ROMERO J, PEDREIRA J, GONZÁLEZ-LAHOZ J. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group. Clin Infect Dis 1996; 23: 585-591.
-
(1996)
Hepatitis-HIV Spanish Study Group. Clin Infect Dis
, vol.23
, pp. 585-591
-
-
Soriano, V.1
Garcia-Samaniego, J.2
Bravo, R.3
Gonzalez, J.4
Castro, A.5
Castilla, J.6
Martínez-Odriozola, P.7
Colmenero, M.8
Carballo, E.9
Suárez, D.10
Rodríguezpiñero, F.J.11
Moreno, A.12
Del Romero, J.13
Pedreira, J.14
González-Lahoz, J.15
-
134
-
-
4444270265
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-Infected patients
-
LAGUNO M, MURILLAS J, BLANCO JL, MARTINEZ E, MIQUEL R, SANCHEZ-TAPIAS JM, BARGALLO X, GARCÍACRIADO A, DE LAZZARI E, LARROUSSE M, LEÓN A, LONCÁ M, MILINKOVIC A, GATELL JM, MALLOLAS J. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-Infected patients. Aids 2004; 18: 27-36.
-
(2004)
Aids
, vol.18
, pp. 27-36
-
-
Laguno, M.1
Murillas, J.2
Blanco, J.L.3
Martinez, E.4
Miquel, R.5
Sanchez-Tapias, J.M.6
Bargallo, X.7
Garcíacriado, A.8
De Lazzari, E.9
Larrousse, M.10
León, A.11
Loncá, M.12
Milinkovic, A.13
Gatell, J.M.14
Mallolas, J.15
-
135
-
-
3342892905
-
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-Coinfected persons
-
AIDS CLINICAL TRIALS GROUP A5071 STUDY TEAM
-
CHUNG RT, ANDERSEN J, VOLBERDING P, ROBBINS GK, LIU T, SHERMAN KE, PETERS
-
(2004)
N Engl J Med
, vol.351
, pp. 451-459
-
-
Chung, R.T.1
Andersen, J.2
Volberding, P.3
Robbins, G.K.4
Liu, T.5
Sherman, K.E.6
Peters, M.G.7
Koziel, M.J.8
Bhan, A.K.9
Alston, B.10
Colquhoun, D.11
Nevin, T.12
Harb, G.13
Van Der Horst, C.14
-
136
-
-
3343012408
-
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-Infected patients
-
APRICOT STUDY GROUP
-
TORRIANI FJ, RODRIGUEZ-TORRES M, ROCKSTROH JK, LISSEN E, GONZALEZ-GARCIA J, LAZZARIN A, CAROSI G, SASADEUSZ J, KATLAMA C, MONTANER J, SETTE H JR, PASSE S, DE PAMPHILIS J, DUFF F, SCHRENK UM, DIETERICH DT; APRICOT STUDY GROUP. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-Infected patients. N Engl J Med 2004; 351: 438-450.
-
(2004)
N Engl J Med
, vol.351
, pp. 438-450
-
-
Torriani, F.J.1
Rodriguez-Torres, M.2
Rockstroh, J.K.3
Lissen, E.4
Gonzalez-Garcia, J.5
Lazzarin, A.6
Carosi, G.7
Sasadeusz, J.8
Katlama, C.9
Montaner, J.10
Sette H, J.R.11
Passe, S.12
De Pamphilis, J.13
Duff, F.14
Schrenk, U.M.15
Dieterich, D.T.16
-
137
-
-
10344230440
-
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-Infected patients: A randomized controlled trial
-
ANRS HCO2 RIBAVIC STUDY TEAM
-
CARRAT F, BANI-SADR F, POL S, ROSENTHAL E, LUNELFABIANI F, BENZEKRI A, MORAND P, GOUJARD C, PIALOUX G, PIROTH L, SALMON-CÉRON D, DEGOTT C, CACOUB P, PERRONNE C; ANRS HCO2 RIBAVIC STUDY TEAM. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-Infected patients: A randomized controlled trial. JAMA 2004; 292: 2839-2848.
-
(2004)
JAMA
, vol.292
, pp. 2839-2848
-
-
Carrat, F.1
Bani-Sadr, F.2
Pol, S.3
Rosenthal, E.4
Lunelfabiani, F.5
Benzekri, A.6
Morand, P.7
Goujard, C.8
Pialoux, G.9
Piroth, L.10
Salmon-Céron, D.11
Degott, C.12
Cacoub, P.13
Perronne, C.14
-
138
-
-
65449136656
-
Diagnosis management, and treatment of hepatitis C: An update
-
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES
-
GHANY MG, STRADER DB, THOMAS DL, SEEFF LB; AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009; 49: 1335-1374.
-
(2009)
Hepatology
, vol.49
, pp. 1335-1374
-
-
Ghany, M.G.1
Strader, D.B.2
Thomas, D.L.3
Seeff, L.B.4
-
139
-
-
33748865593
-
Hepatitis C and B viruses: The new opportunists in HIV infection
-
CHUNG RT. Hepatitis C and B viruses: The new opportunists in HIV infection. Top HIV Med 2006; 14: 78-83.
-
(2006)
Top HIV Med
, vol.14
, pp. 78-83
-
-
Chung, R.T.1
-
140
-
-
0032784036
-
Human immunodeficiency virus infection, anemia, and survival
-
MOORE RD. Human immunodeficiency virus infection, anemia, and survival. Clin Infect Dis 1999; 29: 44-49.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 44-49
-
-
Moore, R.D.1
-
141
-
-
33748751179
-
Zidovudine use but not weight-Based ribavirin dosing impacts anaemia during HCV treatment in HIV-Infected persons
-
ALVAREZ D, DIETERICH DT, BRAU N, MOOREHEAD L, BALL L, SULKOWSKI MS. Zidovudine use but not weight-Based ribavirin dosing impacts anaemia during HCV treatment in HIV-Infected persons. J Viral Hepat 2006; 13: 683-689.
-
(2006)
J Viral Hepat
, vol.13
, pp. 683-689
-
-
Alvarez, D.1
Dieterich, D.T.2
Brau, N.3
Moorehead, L.4
Ball, L.5
Sulkowski, M.S.6
-
142
-
-
0030957788
-
Effects of drugs on 2',3'-Dideoxy-2',3'-Didehydrothymidine phosphorylation in vitro
-
HOGGARD PG, KEWN S, BARRY MG, KHOO SH, BACK DJ. Effects of drugs on 2',3'-Dideoxy-2',3'-Didehydrothymidine phosphorylation in vitro. Antimicrob Agents Chemother 1997; 41: 1231-1236.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 1231-1236
-
-
Hoggard, P.G.1
Kewn, S.2
Barry, M.G.3
Khoo, S.H.4
Back, D.J.5
-
143
-
-
0035956691
-
Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
-
LAFEUILLADE A, HITTINGER G, CHADAPAUD S. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet 2001; 357: 280-281.
-
(2001)
Lancet
, vol.357
, pp. 280-281
-
-
Lafeuillade, A.1
Hittinger, G.2
Chadapaud, S.3
-
144
-
-
0035796119
-
Mitochondrial toxic effects and ribavirin
-
SALMON-CERON D, CHAUVELOT-MOACHON L, ABAD S, SILBERMANN B, SOGNI P. Mitochondrial toxic effects and ribavirin. Lancet 2001; 357: 1803-1804.
-
(2001)
Lancet
, vol.357
, pp. 1803-1804
-
-
Salmon-Ceron, D.1
Chauvelot-Moachon, L.2
Abad, S.3
Silbermann, B.4
Sogni, P.5
-
145
-
-
19544391413
-
Lamivudine for patients with chronic hepatitis B and advanced liver disease
-
CIRRHOSIS ASIAN LAMIVUDINE MULTICENTRE STUDY GROUP
-
LIAW YF, SUNG JJ, CHOW WC, FARREIL G, LEE CZ, YUEN 11, TANWANDEE T, TAO QM, SHUE K, KEENE ON, DIXON JS, GRAY DF, SABBAT J; CIRRHOSIS ASIAN LAMIVUDINE MULTICENTRE STUDY GROUP. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Eng J Med 2004; 351: 1521-1531.
-
(2004)
N Eng J Med
, vol.351
, pp. 1521-1531
-
-
Liaw, Y.F.1
Sung, J.J.2
Chow, W.C.3
Farreil, G.4
Lee, C.Z.5
Yuen, L.L.6
Tanwandee, T.7
Tao, Q.M.8
Shue, K.9
Keene, O.N.10
Dixon, J.S.11
Gray, D.F.12
Sabbat, J.13
-
146
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
LOK AS, MCMAHON BJ. Chronic hepatitis B: Update 2009. Hepatology 2009; 50: 661-662.
-
Hepatology
, vol.2009
, Issue.50
, pp. 661-662
-
-
Lok, A.S.1
Mcmahon, B.J.2
|